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Accepted 19 September 2011A 42-year-old, gravida 5, para 2, woman underwent
amniocentesis at 18 weeks of gestation because of advanced
maternal age. She had experienced two spontaneous abortionsFig. 1. A karyotype
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There was no family history of congenital malformations. In
six out of 15 separated colonies of cultured amniocytes, anof 47,XY,þ9.
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Fig. 2. Array comparative genomic hybridization analysis of uncultured amniocytes shows genomic imbalance and gene dosage increase in chromosome 9.
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Fig. 3. Interphase fluorescence in situ hybridization analysis of uncultured
amniocytes shows (A) three signals in a cell with trisomy 9 and (B) two signals
in a cell with disomy 9, consistent with the diagnosis of mosaic trisomy 9.
Fig. 4. Representative electrophoretograms of quantitative fluorescent poly-
merase chain reaction assays. The marker D9S2149 (9p21.1) shows two peaks
(143 bp: 159 bp; maternal: paternal) of unequal fluorescent activity from two
different parental alleles in the sampling tissues with maternal:paternal dosage
ratios of 1.66:1, 1.08:1, 1.19:1 and 2:1, respectively, in uncultured amniocytes,
cultured amniocytes, umbilical cord and placenta.
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the other nine colonies had a karyotype of 46,XY. The cyto-
genetic result of amniocentesis was 47,XY,þ9[6]/46,XY[9].
The parental karyotypes were normal. The woman requested
a repeat amniocentesis at 20 weeks of gestation when the
ultrasound revealed that the fetal biometry was equivalent to 18
weeks. Array comparative genomic hybridization (aCGH)
analysis of uncultured amniocytes using oligonucleotide-based
aCGH of CytoChip Oligo Array (BlueGnome, Cambridge, UK)
revealed genomic imbalance and gene dosage increase in
chromosome 9 (Fig. 2). Fluorescence in situ hybridization
(FISH) analysis of uncultured interphase amniocytes using
Vysis CEP 9 Alpha SpectrumOrange DNA probe (Vysis,
Downers Grove, IL, USA) showed three signals in 12 out of 25uncultured amniocytes and two signals in the remaining 13
amniocytes, indicating 48% (12/25) mosaicism for trisomy 9
(Fig. 3). Quantitative fluorescent polymerase chain reaction
(QF-PCR) analysis of uncultured amniocytes using informative
microsatellite markers specific for chromosome 9 revealed
a diallelic pattern with unequal biparental inheritance of chro-
mosome 9 with a dosage ratio of 1.66:1 (maternal: paternal),
indicating a maternal origin of mosaic trisomy 9 (Fig. 4).
Cytogenetic analysis of cultured amniocytes revealed a karyo-
type of 47,XY,þ9[6]/46,XY[18]. The parents decided to
terminate the pregnancy at 23 weeks of gestation. Prenatal
ultrasound revealed a small-for-gestational-age fetus with fetal
biometry equivalent to 21 weeks. A 482-g malformed fetus was
delivered with hypertelorism, a large forehead, a bulbous nose,
Fig. 5. The fetus at birth.
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upper lip (Fig. 5). Uniparental disomy (UPD) 9 was excluded.
Cytogenetic analyses of the fetal and extraembryonic tissues
showed a karyotype of 47,XYþ9[5]/46,XY[35] in the cord
blood, a karyotype of 47,XYþ9[5]/46,XY[35] in the umbilical
cord, and a karyotype of 47,XYþ9 (40 cells) in the placenta.
The results of QF-PCR analyses of cultured amniocytes and
uncultured umbilical cord were consistent with mosaic trisomy
9, and the result of QF-PCR analysis of uncultured placental
tissues was consistent with trisomy 9 of maternal origin
(Fig. 4).
Mosaic or non-mosaic trisomy 9 is characterized by mental
retardation, growth restriction, facial dysmorphim, low-set
ears, microphthalmia, a bulbous nose, a small mouth,
a high-arched palate, congenital heart defects (most commonly
ventricular septal defect), genitourinary anomalies (hypo-
plastic genitalia, cryptorchidism, cystic kidneys, or hydro-
nephrosis), skeletal anomalies (joint dislocations or
deformations), and central nervous system anomalies (hydro-
cephalus or Dandy-Walker malformation) [1e3]. The present
case prenatally manifested intrauterine growth restriction
(IUGR), but was not associated with major anomalies. In
a review of 37 cases of prenatally detected mosaic trisomy 9,
Chen et al. [3] found that 64.9% (24/37) of the cases were
associated with phenotypic abnormalities. In a study of 12
individuals of long-term survivors with trisomy 9 mosaicism,
Bruns [4] reported a mean (standard deviation, SD) birth
weight of 2228.6 g (547.72 g) (range: 1361e3232 g) for
a mean gestational age of 38 weeks. IUGR has been reported
to be a prenatal ultrasound finding of mosaic trisomy 9 [5e7].
In the present case, the placenta had trisomy 9. We speculate
that IUGR in the present case may be in part caused by
a trisomy 9 placenta and placental dysfunction.
The interphase FISH study of uncultured amniocytes, as
shown in this presentation, is an efficient method for confir-
mation of the status of mosaic trisomy 9 detected atamniocentesis. Chen et al. [3] previously showed that aCGH
was unable to detect 18% (9/50) of mosaic trisomy 9 in the
uncultured amniocytes. In this study, aCGH and QF-PCR were
able to detect mosaic trisomy 9 under the circumstance of 48%
(12/25) mosaic trisomy 9 in the uncultured amniocytes. The
present case was not associated with UPD 9. Mosaic trisomy 9
has been reported to be associated with UPD 9, and QF-PCR
provides the advantages of detecting both mosaicism and
UPD.
In conclusion, mosaic trisomy 9 at amniocentesis can be
associated with IUGR and trisomy 9 in the placenta. Molec-
ular cytogenetic technologies such as interphase FISH, aCGH
and QF-PCR using uncultured amniocytes are useful for rapid
confirmation of high-level mosaicism for trisomy 9 detected at
amniocentesis.Acknowledgments
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